Search

Search results

375 results found

Jarom Chung

Jarom Chung, PhD Director of Product at Lucid Inc.

Arata Sano

Arata graduated from Kyoto Prefectural University of Medicine in 2013. He began his career as a cardiologist at Kurashiki Central Hospital. In 2019, he returned to Kyoto Prefectural University of Medicine to pursue a PhD, where he has been deeply engaged in cardiovascular research. Arata is a board...

Targeting Liver Epsins Ameliorates Dyslipidemia in Atherosclerosis through Inhibition of Proprotein Convertase Subtilisin/Kexin Type 9-Mediated Low-density Lipoprotein Receptor Degradation

Zhu, Bo, Krishan Gupta, Kui Cui, Beibei Wang, Marina V. Malovitchko, Kathryn S. Li, Hao Wu, et al. 2024. “Targeting Liver Epsins Ameliorates Dyslipidemia in Atherosclerosis through Inhibition of Proprotein Convertase Subtilisin/Kexin Type 9-Mediated Low-Density Lipoprotein Receptor Degradation”. BioRxiv 2024.08.26.609742.

Ran Jing, Ph.D. - Boston Children's Hospital/Harvard Medical School

Dr. Ran Jing is a stem cell biologist and immunologist at Harvard Medical School and Boston Children's Hospital. Dr. Jing's research focuses on decoding the intricacies of lymphoid development using innovative models like iPSC-derived T and NK cells. Concurrently, we employ cell engineering, regenerative medicine, and synthetic biology to create off-the-shelf CAR T cell immunotherapies for cancer and autoimmune diseases.

Navaneethakrishna Makaram, PhD

he/him
I am a Postdoctoral Research Fellow at Harvard Medical School and the FNNDSC of Boston Children’s Hospital (BCH) under the mentorship of Dr. Tamilia. My research revolves around the analysis of electroencephalography (EEG) data from children with epilepsy and their integration with neuroimaging...